<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">Phytochemicals have been recognized also as origin of traditional medicinal used in the history and in hot demand in parts of the world today (
 <xref rid="b0055" ref-type="bibr">Bussmann and Sharon, 2006</xref>). Mangifera has been recorded as belonging to 69 species, classified with three subgenus widely distributed in Asia, namely Bangladesh, Malaysia, Philippines, Thailand, India (
 <xref rid="b0110" ref-type="bibr">Hayati et al., 2018</xref>). Traditionally 
 <italic>Mangifera longipes</italic> Griff. (Family: Anacardiaceae) bark reported for the cure of diarrhea, iron deficiency, syphilis, ringworm, dysentery, leprosy, skin abscesses and infections (
 <xref rid="b0230" ref-type="bibr">Prashanth et al., 2001</xref>); leaves for excessive GI (gastrointestinal) motility and wounds (
 <xref rid="b0195" ref-type="bibr">Makare et al., 2001</xref>); fruit for the use of xerophthalmia, vitamin A deficiency, skin infection (
 <xref rid="b0170" ref-type="bibr">Khan et al., 2015</xref>); roots also used for the sores, leucorrhea, syphilis (
 <xref rid="b0085" ref-type="bibr">Ediriweera et al., 2017</xref>) and seeds for the medication of indigestion, cholera, astringency, anthelmintics (
 <xref rid="b0165" ref-type="bibr">Kawamura et al., 2011</xref>). However, Quercus had been identified 91 species (
 <xref rid="b0075" ref-type="bibr">Deng et al., 2014</xref>), whereas 
 <italic>Quercus gomeziana</italic> (Family: Fagaceae) and its species were historically used for the treatment of styptic, bacterial infection (
 <xref rid="b0035" ref-type="bibr">Berahou et al., 2007</xref>), anthelmintics, cytotoxic, viral infection (
 <xref rid="b0210" ref-type="bibr">Paaver et al., 2010</xref>), astringent, larvicidal (
 <xref rid="b0260" ref-type="bibr">Redwane et al., 2002</xref>), gastrointestinal (GI) disorder, ulcers (
 <xref rid="b0155" ref-type="bibr">Joshi and Juyal, 2017</xref>), wound healing, chronic toxicity (
 <xref rid="b0180" ref-type="bibr">Khattak, 2018</xref>), diarrhea, asthma, inflammation (
 <xref rid="b0185" ref-type="bibr">Khennouf et al., 2010</xref>), hemostatic, gastropathies, hemorrhoid (
 <xref rid="b0310" ref-type="bibr">Taib et al., 2020</xref>). There are currently available drugs that are desensitizing to receptors and immune to microorganisms such as bacteria, which is why new lead compounds are required that will be more sensitive with a definite receptor to give batter action and to overcome resistance (
 <xref rid="b0050" ref-type="bibr">Bristy et al., 2020</xref>).
</p>
